Ovid Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Mar 24 | BuyUS$50,364 | Jeremy Levin | Individual | 18,248 | US$2.76 |
Insider Trading Volume
Insider Buying: OVID insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,383 | 0.00619% |
Individual Insiders | 3,701,655 | 5.23% |
Public Companies | 7,531,996 | 10.6% |
General Public | 15,056,649 | 21.3% |
Hedge Funds | 21,932,929 | 31% |
Institutions | 22,583,049 | 31.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,531,996 | US$23.0m | 0% | no data | |||
6,851,051 | US$20.9m | 0% | 0.53% | |||
6,117,400 | US$18.7m | 0% | 0.61% | |||
5,315,969 | US$16.2m | -2.39% | 0.54% | |||
4,319,918 | US$13.2m | 22.7% | no data | |||
3,652,196 | US$11.1m | 0.5% | no data | |||
3,648,509 | US$11.1m | 0% | 1.57% | |||
2,989,777 | US$9.1m | 0.79% | no data | |||
2,500,000 | US$7.6m | 0% | 0.22% | |||
1,655,871 | US$5.1m | -2.67% | 0.01% | |||
1,475,260 | US$4.5m | -2.06% | no data | |||
1,319,679 | US$4.0m | 0% | 14.9% | |||
1,232,923 | US$3.8m | 2.68% | no data | |||
1,120,347 | US$3.4m | 1.02% | no data | |||
864,822 | US$2.6m | 0% | 0.92% | |||
557,790 | US$1.7m | -1.54% | 0.03% | |||
490,672 | US$1.5m | 2.48% | no data | |||
430,247 | US$1.3m | 0% | no data | |||
395,774 | US$1.2m | 0% | 0.1% | |||
344,634 | US$1.1m | 0% | 0.82% | |||
243,295 | US$742.1k | 70.3% | no data | |||
229,553 | US$700.1k | -7.74% | no data | |||
161,808 | US$493.5k | 0% | no data | |||
153,873 | US$469.3k | 44.1% | no data | |||
144,500 | US$440.7k | -3.67% | 0.04% |